An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS‐R myelodysplastic syndrome patients into prognostically significant groups
暂无分享,去创建一个
F. Ortuño | A. Hurtado | T. Chen-Liang | A. Jerez | V. Vicente | M. García-Malo | A. M. Casado-Prieto | V. Campos-Rodríguez | M. Amigo | M. Amigo | Vicente Vicente | Andrés Jerez | A. M. Casado‐Prieto | F. Ortuño